Randall Holcombe to become University of Hawaii Cancer Center Director
Randall F. Holcombe, MD, MBA, currently Deputy Director of the NCI-designated Tisch Cancer Institute at Mount Sinai and Chief Medical Officer for Cancer for the Mount Sinai Health System in New York, will assume the role of Director, University of Hawaii Cancer Center on October 1, 2016.
The UH Cancer Center was founded in 1981 and became an NCI-designated Cancer Center in 1996. Its mission is to reduce the cancer burden through research, education and outreach with an emphasis on the unique ethic, cultural and environmental characteristics of Hawaii and the Pacific. This emphasis provides a foundation for the epidemiologic and cancer prevention research focused on Hawaii’s multiethnic community as well as research into the development of agents with anti-cancer activity derived from natural resources unique to the Pacific ecosystem.
Dr. Holcombe will work to expand the laboratory and population-based research activities, promote translational and clinical research with UH Cancer Center’s clinical partners and strengthen already substantial cancer education and outreach activities.
Dr. Holcombe has been an active member of AACI since 2010 and has served on the Clinical Research Initiative and Physicians’ Clinical Leadership Initiative (PCLI) Steering Committees. He is currently Chair of the AACI PCLI Steering Committee.